The dopamine D2 receptor gene DRD2 and the nicotinic acetylcholine receptor gene CHRNA4 interact on striatal gray matter volume: Evidence from a genetic imaging study

NeuroImage

Volumn 64, Issue 1, 2013, Pages 167-172

  Markett, Sebastian ^a   Reuter, Martin ^a   Montag, Christian ^a   Weber, Bernd ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Basal ganglia; CHRNA4; DRD2; Genetic imaging; Voxel based morphometry; Working memory

Indexed keywords

CYTOSINE; DOPAMINE 2 RECEPTOR; NICOTINIC RECEPTOR; THYMINE;

ADULT; ARTICLE; BEHAVIOR; BRAIN SIZE; CHRNA4 GENE; CORPUS STRIATUM; DRD2 GENE; FEMALE; GENE; GRAY MATTER; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL CAPACITY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; VOXEL BASED MORPHOMETRY; WORKING MEMORY;

ADULT; CORPUS STRIATUM; HUMANS; MALE; MEMORY, SHORT-TERM; ORGAN SIZE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECEPTORS, DOPAMINE D2; RECEPTORS, NICOTINIC;

EID: 84867297977     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.08.059     Document Type: Article

References (57)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
2. Baddeley A.D. Working Memory 1986, University Press, Oxford. 1. ed.
3. Baddeley A.D. Working memory: looking back and looking forward. Nat. Rev. Neurosci. 2003, 4(10):829-839.
4. Baddeley A.D., Hitch G.J. Working memory. Recent Advances in Learning and Motivation 1974, 47-89. Academic Press, New York. 8. ed. G. Bower (Ed.).
5. Betcheva E.T., Mushiroda T., Takahashi A., Kubo M., Karachanak S.K., Zaharieva I.T., Vazharova R.V., Dimova I.I., Milanova V.K., Tolev T., Kirov Ge, Owen M.J., O'Donovan M.C., Kamatani N., Nakamura Y., Toncheva D.I. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J. Hum. Genet. 2009, 54(2):98-117.
6. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-omethyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29(11):1943-1961.
7. Cerasa A., Gioia M.C., Tarantino P., Labate A., Arabia G., Annesi G., et al. The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals. Genes Brain Behav. 2009, 8(4):459-463.
8. Chu C.-J., Yang Y.-C., Wei J.-X., Zhang L. Association of nicotinic acetylcholine receptor subunit alpha-4 polymorphisms with smoking behaviors in Chinese male smokers. Chin. Med. J. 2011, 124(11):1634-1638.
9. Colzato L.S., van den Wildenberg W.P.M., der Does A.J.W.V., Hommel B. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 2010, 170(3):782-788.
10. Cools R., Sheridan M., Jacobs E., D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J. Neurosci. 2007, 27(20):5506-5514.
11. Cools R., Gibbs S.E., Miyakawa A., Jagust W., D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J. Neurosci. 2008, 28(5):1208-1212.
12. Dehaene S., Kerszberg M., Changeux J.P. A neuronal model of a global workspace in effortful cognitive tasks. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(24):14529-14534.
13. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12(3):205-216.
14. Espeseth T., Endestad T., Rootwelt H., Reinvang I. Nicotine receptor gene CHRNA44 modulates early event-related potentials in auditory and visual oddball target detection tasks. Neuroscience 2007, 147(4):974-985.
15. Exley R., Cragg S.J. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic alter of striatal dopamine neurotransmission. Br. J. Pharmacol. 2008, 153(Suppl. 1):S283-S297.
16. Feng Y., Niu T., Xing H., Xu X., Chen C., Peng S., et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am. J. Hum. Genet. 2004, 75(1):112-121.
17. Friedman N.P., Miyake A., Young S.E., Defries J.C., Corley R.P., Hewitt J.K. Individual differences in executive functions are almost entirely genetic in origin. J. Exp. Psychol. Gen. 2008, 137(2):201-225.
18. Goldman-Rakic P.S. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 1996, 351(1346):1445-1453.
19. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991, 41(1):1-24.
20. Greenwood P.M., Fossella J.A., Parasuraman R. Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention. J. Cogn. Neurosci. 2005, 17(10):1611-1620.
21. Hänninen K., Katila H., Kampman O.I., Anttila S., Illi A., Rontu R., Mattila K.M., Hietala J., Hurme M., Leinonen E., Lehtimäki T. Association between the c957t polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci. Lett. 2006, 407(3):195-198.
22. Hariri A.R., Drabant E.M., Weinberger D.R. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol. Psychiatry 2006, 59(10):888-897.
23. Hazy T.E., Frank M.J., O'Reilly R.C. Towards an executive without a homunculus: computational models of the prefrontal cortex/basal ganglia system. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2007, 362(1485):1601-1613.
24. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol. Psychiatry 2004, 9(12):1060-1061.
25. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009, 63(10):907-912.
26. Hoenicka J., Aragüés M., Rodríguez-Jiménez R., Ponce G., Martínez I., Rubio G., Jiménez-Arriero M.A., Palomo T. C957T polymorphism associated with schizophrenia in Spanish patients. Acta Psychiatr. Scand. 2006, 114(6):435-438.
27. Jacobsen L.K., Pugh K.R., Mencl W.E., Gelernter J. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology 2006, 188(4):530-540.
28. Kremen W.S., Jacobsen K.C., Xian H., Eisen S.A., Eaves L.J., Tsuang M.T., et al. Genetics of verbal working memory processes: a twin study of middle-aged men. Neuropsychology 2007, 21(5):569-580.
29. Lawford B.R., Young R., Swagell C.D., Barnes M., Burton S.C., Ward W.K., Heslop K.R., Shadforth S., van Daal A., Morris C.P. The C/C genotype of the c957t polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr. Res. 2005, 73(1):31-37.
30. Levin E.D., Rose J.E. Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res. Bull. 1991, 27(1):125-128.
31. Levin E.D., Castonguay M., Ellison G.D. Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav. Neural Biol. 1987, 48(2):206-212.
32. Levin E.D., McGurk S.R., Rose J.E., Butcher L.L. Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555. Pharmacol. Biochem. Behav. 1989, 33(4):919-922.
33. Levin E.D., Conners C.K., Silva D., Hinston S.C., Meck W.H., March J., Rose J.E. Transdermal nicotine effect on attention. Psychopharmacology 1998, 140:135-141.
34. Luciana M., Depue R.A., Arbisi P., Leon A. Facilitation of working memory in humans by a D2 dopamine receptor agonist. J. Cogn. Neurosci. 1992, 4(1):58-68.
35. Luciana M., Collins P.F., Depue R.A. Opposing roles of dopamine and serotonin in the modulation of human spatial working memory functions. Cereb. Cortex 1998, 8:218-226.
36. Markett S., Montag C., Reuter M. The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA44. J. Cogn. Neurosci. 2010, 22(9):1944-1954.
37. Markett S., Montag C., Walter N.T., Reuter M. Evidence for the modality independence of the genetic epistasis between the dopaminergic and cholinergic system on working memory capacity. Eur. Neuropsychopharmacol. 2011, 21:216-220.
38. Markett S., Montag C., Reuter M. The nicotinic acetylcholine receptor gene CHRNA44 is associated with negative emotionality. Emotion 2011, 11(2):450-455.
39. Marubio L.M., Gardier A.M., Durier S., David D., Klink R., Arroyo-Jimenez M.M., et al. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur. J. Neurosci. 2003, 17(7):1329-1337.
40. McGurk S.R., Levin E.D., Butcher L.L. Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. Psychopharmacology 1989, 99(3):371-373.
41. McNab F., Klingberg T. Prefrontal cortex and basal ganglia control access to working memory. Nat. Neurosci. 2008, 11(1):103-107.
42. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24:167-202.
43. Monakhov M., Golimbet V., Abramova L., Kaleda V., Karpov V. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr. Res. 2008, 100(1-3):302-307.
44. Montag C., Weber B., Jentgens E., Elger C., Reuter M. An epistasis effect of functional variants on the BDNF and DRD2 genes modulates gray matter volume of the anterior cingulate cortex in healthy humans. Neuropsychologia 2010, 48(4):1016-1021.
45. Montag C., Kirsch P., Sauer C., Markett S., Reuter M. The role of the CHRNA4 gene in internet addiction: a case-control study. J. Addict. Med. 2012, 6:191-195.
46. Parasuraman R., Greenwood P.M., Kumar R., Fossella J. Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychol. Sci. 2005, 16(3):200-207.
47. Parish C.L., Nunan J., Finkelstein D.I., McNamara F.N., Wong J.Y., Waddington J.L., et al. Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. Mol. Pharmacol. 2005, 68(5):1376-1386.
48. Plomin R., Pedersen N.L., Lichtenstein P., McClearn G.E. Variability and stability in cognitive abilities are largely genetic later in life. Behav. Genet. 1994, 24(3):207-215.
49. Reinvang I., Lundervold A.J., Rootwelt H., Wehling E., Espeseth T. Individual variation in a cholinergic receptor gene modulates attention. Neurosci. Lett. 2009, 453(3):131-134.
50. Rodriguez-Jimenez R., Hoenicka J., Jimenez-Arriero M.A., Ponce G., Bagney A., Aragues M., Palomo T. Performance in the Wisconsin Card Sorting Test and c957t polymorphism on the DRD2 gene in healthy volunteers. Neuropsychobiology 2006, 54(3):166-170.
51. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
52. Takeuchi H., Taki Y., Sassa Y., Hashizume H., Sekiguchi A., Fukushima A., Kawashima R. Working memory training using mental calculation impacts regional gray matter of the frontal and parietal regions. PLoS One 2011, 6(8):e23175.
53. Tsai S.-J., Yeh H.-L., Hong C.-J., Liou Y.-J., Yang A.C., Liu M.-E., et al. Association of CHRNA4 polymorphism with depression and loneliness in elderly males. Genes Brain Behav. 2012, 11(2):230-234.
54. Vogel E.K., McCollough A.W., Machizawa M.G. Neural measures reveal individual differences in controlling access to working memory. Nature 2005, 438(7067):500-503.
55. Winterer G., Musso F., Konrad A., Vucurevic G., Stoeter P., Sander T., et al. Association of attentional network function with exon 5 variations of the CHRNA44 gene. Hum. Mol. Genet. 2007, 16(18):2165-2174.
56. Xu H., Kellendonk C.B., Simpson E.H., Keilp J.G., Bruder G.E., Polan H.J., et al. DRD2 c957t polymorphism interacts with the COMT val158met polymorphism in human working memory ability. Schizophr. Res. 2007, 90(1-3):104-107.
57. Zhou F.-M., Wilson C., Dani J.A. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 2003, 9(1):23-36.